Thyroid expert Dr. Antonio C. Bianco, MD, PhD, speaking at the American Association of Clinical Endocrinology (AACE) annual meeting, has just acknowledged that many patients (he says 10 – 20%, but as you will agree, this percentage is much larger), treated for hypothyroidism using levothyroxine (T4, the “number one prescribed drug in the country”), fail to experience an improvement in their symptoms.
Of course, this isn’t news to those of you who are familiar with abnormal thyroid function.
However the fact is that a major player in traditional medicine is willing to admit that something is wrong with medical doctors’ usual treatment for hypothyroidism.
So: it seems that our doctors’ understanding of the problem is improving.
That’s REALLY encouraging!
Dr. Bianco, further to his credit, has noted that combination therapy with T4 and T3 doesn’t entirely solve the problem for folks with low thyroid function (as you may know, slow-release T3 is the best way to go).
However it seems that the medical establishment is not yet ready to embrace the idea of treating Hypothyroidism with slow-release T3.
If you would like to read about Dr. Bianco’s article, please see “Debate Continues on Combination Therapy for Hypothyroidism“, by Miriam E. Tucker, dated May 20, 2022
the URL for this article is https://www.medscape.com/viewarticle/974330